These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 24332628)

  • 1. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
    Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
    Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL
    Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors.
    Luo Y; Zhang LR; Hu Y; Zhang S; Fu J; Wang XM; Zhu HL
    ChemMedChem; 2012 Sep; 7(9):1587-93. PubMed ID: 22811397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
    Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.
    Duan YT; Wang ZC; Sang YL; Tao XX; Teraiya SB; Wang PF; Wen Q; Zhou XJ; Ding L; Yang YH; Zhu HL
    Eur J Med Chem; 2014 Apr; 76():387-96. PubMed ID: 24594526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K; Xue JY; Zhu HL
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
    ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.
    Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL
    Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
    Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R
    Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis.
    Wang ZC; Duan YT; Qin YJ; Wang PF; Luo Y; Wen Q; Yang YA; Sun J; Hu Y; Sang YL; Zhu HL
    Eur J Med Chem; 2013 Jul; 65():456-63. PubMed ID: 23770447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
    Qin YJ; Wang PF; Makawana JA; Wang ZC; Wang ZN; Yan-Gu ; Jiang AQ; Zhu HL
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5279-83. PubMed ID: 25587588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and molecular docking of 1,4-benzodioxane thiazolidinedione piperazine derivatives as FabH inhibitors.
    Sun J; He W; Liu HY; Qin J; Ye CL
    Bioorg Chem; 2019 Jul; 88():102958. PubMed ID: 31054434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.
    Wang YT; Shi TQ; Fu J; Zhu HL
    Eur J Med Chem; 2019 Jun; 171():209-220. PubMed ID: 30925337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
    Segretti ND; Serafim RA; Segretti MC; Miyata M; Coelho FR; Augusto O; Ferreira EI
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3988-93. PubMed ID: 27426865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y; Yang YS; Song XD; Lu L; Zhu HL
    Chem Pharm Bull (Tokyo); 2017; 65(2):178-185. PubMed ID: 28154310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.